Acumen Pharmaceuticals, Inc. (ABOS)

$4.63

-0.12 (-2.53%)
Rating:
Recommendation:
-
Symbol ABOS
Price $4.63
Beta 0.000
Volume Avg. 0.06M
Market Cap 187.529M
Shares () -
52 Week Range 3.02-16.29
1y Target Est -
DCF Unlevered ABOS DCF ->
DCF Levered ABOS LDCF ->
ROE -14.31% Sell
ROA -14.90% Sell
Operating Margin -
Debt / Equity 2.50% Neutral
P/E -
P/B 0.91 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ABOS news


Healthcare
Biotechnology
NASDAQ Global Select

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.